Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark P Thomas

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Chemmedchem|May 25, 2011
Aromatase and dual aromatase-steroid sulfatase inhibitors from the letrozole and vorozole templatesPaul M Wood, L W Lawrence Woo, Mark P Thomas, et al.
Chemmedchem|May 25, 2011
Discovery of adamantyl heterocyclic ketones as potent 11β-hydroxysteroid dehydrogenase type 1 inhibitorsXiangdong Su, Nigel Vicker, Mark P Thomas, et al.
Journal of Medicinal Chemistry|January 18, 2012
Contribution of phosphates and adenine to the potency of adenophostins at the IP₃ receptor: synthesis of all possible bisphosphates of adenophostin AKana M Sureshan, Andrew M Riley, Mark P Thomas, et al.
European Journal of Applied Physiology|June 4, 2020
The day-to-day reliability of peak fat oxidation and FAT<sub>MAX</sub>Oliver J Chrzanowski-Smith, Robert M Edinburgh, Mark P Thomas, et al.
International Journal of Sport Nutrition and Exercise Metabolism|February 15, 2021
Determinants of Peak Fat Oxidation Rates During Cycling in Healthy Men and WomenOliver J Chrzanowski-Smith, Robert M Edinburgh, Mark P Thomas, et al.
ACS Chemical Biology|February 15, 2012
A synthetic polyphosphoinositide headgroup surrogate in complex with SHIP2 provides a rationale for drug discoveryStephen J Mills, Camilla Persson, Gyles Cozier, et al.
ACS Medicinal Chemistry Letters|January 17, 2012
Steroidomimetic Tetrahydroisoquinolines for the Design of New Microtubule DisruptorsMathew P Leese, Fabrice Jourdan, Wolfgang Dohle, et al.
Anticancer Research|September 27, 2015
The In Vitro and In Vivo Activity of the Microtubule Disruptor STX140 Is Mediated by Hif-1 Alpha and CAIX ExpressionChloe Stengel, Simon P Newman, Mathew P Leese, et al.
Chemmedchem|October 13, 2011
Structure-activity relationship for the first-in-class clinical steroid sulfatase inhibitor Irosustat (STX64, BN83495)L W Lawrence Woo, Dharshini Ganeshapillai, Mark P Thomas, et al.
Chemmedchem|May 21, 2010
Discovery of adamantyl ethanone derivatives as potent 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) inhibitorsXiangdong Su, Fabienne Pradaux-Caggiano, Mark P Thomas, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Chemmedchem|May 25, 2011
Aromatase and dual aromatase-steroid sulfatase inhibitors from the letrozole and vorozole templatesPaul M Wood, L W Lawrence Woo, Mark P Thomas, et al.
Chemmedchem|May 25, 2011
Discovery of adamantyl heterocyclic ketones as potent 11β-hydroxysteroid dehydrogenase type 1 inhibitorsXiangdong Su, Nigel Vicker, Mark P Thomas, et al.
Journal of Medicinal Chemistry|January 18, 2012
Contribution of phosphates and adenine to the potency of adenophostins at the IP₃ receptor: synthesis of all possible bisphosphates of adenophostin AKana M Sureshan, Andrew M Riley, Mark P Thomas, et al.
European Journal of Applied Physiology|June 4, 2020
The day-to-day reliability of peak fat oxidation and FAT<sub>MAX</sub>Oliver J Chrzanowski-Smith, Robert M Edinburgh, Mark P Thomas, et al.
International Journal of Sport Nutrition and Exercise Metabolism|February 15, 2021
Determinants of Peak Fat Oxidation Rates During Cycling in Healthy Men and WomenOliver J Chrzanowski-Smith, Robert M Edinburgh, Mark P Thomas, et al.
ACS Chemical Biology|February 15, 2012
A synthetic polyphosphoinositide headgroup surrogate in complex with SHIP2 provides a rationale for drug discoveryStephen J Mills, Camilla Persson, Gyles Cozier, et al.
ACS Medicinal Chemistry Letters|January 17, 2012
Steroidomimetic Tetrahydroisoquinolines for the Design of New Microtubule DisruptorsMathew P Leese, Fabrice Jourdan, Wolfgang Dohle, et al.
Anticancer Research|September 27, 2015
The In Vitro and In Vivo Activity of the Microtubule Disruptor STX140 Is Mediated by Hif-1 Alpha and CAIX ExpressionChloe Stengel, Simon P Newman, Mathew P Leese, et al.
Chemmedchem|October 13, 2011
Structure-activity relationship for the first-in-class clinical steroid sulfatase inhibitor Irosustat (STX64, BN83495)L W Lawrence Woo, Dharshini Ganeshapillai, Mark P Thomas, et al.
Chemmedchem|May 21, 2010
Discovery of adamantyl ethanone derivatives as potent 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) inhibitorsXiangdong Su, Fabienne Pradaux-Caggiano, Mark P Thomas, et al.
Pageof 6